AMICUS THERAPEUTICS, INC. Revenue
AMICUS THERAPEUTICS, INC. reported Revenue of $634.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $185.21M, a 23.72% increase year-over-year.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $169.06M, a 19.46% increase year-over-year.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $154.69M, a 22.12% increase year-over-year.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $125.25M, a 13.45% increase year-over-year.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $634.21M, a 20.05% increase from fiscal 2024.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $528.29M, a 32.29% increase from fiscal 2023.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $399.36M, a 21.30% increase from fiscal 2022.
- AMICUS THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $329.23M, a 7.76% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $185.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $354.27M derived: sum of 2 quarters · filed 2026-02-20 | $508.96M derived: sum of 3 quarters · filed 2026-02-20 | $634.21M 10-K · filed 2026-02-20 |
| 2025-09-30 | $169.06M 10-Q · filed 2025-11-04 | $323.75M derived: sum of 2 quarters · filed 2025-11-04 | $449.00M 10-Q · filed 2025-11-04 | $598.70M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-06-30 | $154.69M 10-Q · filed 2025-07-31 | $279.94M 10-Q · filed 2025-07-31 | $429.64M derived: sum of 3 quarters · filed 2026-02-20 | $571.16M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-03-31 | $125.25M 10-Q · filed 2025-05-01 | $274.95M derived: sum of 2 quarters · filed 2026-02-20 | $416.47M derived: sum of 3 quarters · filed 2026-02-20 | $543.14M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-12-31 | $149.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $291.22M derived: sum of 2 quarters · filed 2026-02-20 | $417.89M derived: sum of 3 quarters · filed 2026-02-20 | $528.29M 10-K · filed 2026-02-20 |
| 2024-09-30 | $141.52M 10-Q · filed 2025-11-04 | $268.19M derived: sum of 2 quarters · filed 2025-11-04 | $378.59M 10-Q · filed 2025-11-04 | $493.67M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $126.67M 10-Q · filed 2025-07-31 | $237.07M 10-Q · filed 2025-07-31 | $352.15M derived: sum of 3 quarters · filed 2026-02-20 | $455.65M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $110.40M 10-Q · filed 2025-05-01 | $225.49M derived: sum of 2 quarters · filed 2026-02-20 | $328.99M derived: sum of 3 quarters · filed 2026-02-20 | $423.49M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $115.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $218.58M derived: sum of 2 quarters · filed 2026-02-20 | $313.09M derived: sum of 3 quarters · filed 2026-02-20 | $399.36M 10-K · filed 2026-02-20 |
| 2023-09-30 | $103.50M 10-Q · filed 2024-11-06 | $198.00M derived: sum of 2 quarters · filed 2024-11-06 | $284.27M 10-Q · filed 2024-11-06 | $372.37M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $94.50M 10-Q · filed 2024-08-08 | $180.77M 10-Q · filed 2024-08-08 | $268.87M derived: sum of 3 quarters · filed 2025-02-19 | $350.56M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $86.27M 10-Q · filed 2024-05-09 | $174.37M derived: sum of 2 quarters · filed 2025-02-19 | $256.06M derived: sum of 3 quarters · filed 2025-02-19 | $336.79M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $88.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $169.79M derived: sum of 2 quarters · filed 2025-02-19 | $250.52M derived: sum of 3 quarters · filed 2025-02-19 | $329.23M 10-K · filed 2025-02-19 |
| 2022-09-30 | $81.69M 10-Q · filed 2023-11-08 | $162.42M derived: sum of 2 quarters · filed 2023-11-08 | $241.14M 10-Q · filed 2023-11-08 | $323.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $80.73M 10-Q · filed 2023-08-08 | $159.45M 10-Q · filed 2023-08-08 | $241.60M derived: sum of 3 quarters · filed 2024-02-28 | $321.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $78.72M 10-Q · filed 2023-05-10 | $160.87M derived: sum of 2 quarters · filed 2024-02-28 | $240.41M derived: sum of 3 quarters · filed 2024-02-28 | $317.83M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $82.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $161.70M derived: sum of 2 quarters · filed 2024-02-28 | $239.11M derived: sum of 3 quarters · filed 2024-02-28 | $305.51M 10-K · filed 2024-02-28 |
| 2021-09-30 | $79.55M 10-Q · filed 2022-11-07 | $156.96M derived: sum of 2 quarters · filed 2022-11-07 | $223.36M 10-Q · filed 2022-11-07 | $293.93M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $77.41M 10-Q · filed 2022-08-04 | $143.81M 10-Q · filed 2022-08-04 | $214.39M derived: sum of 3 quarters · filed 2023-03-01 | $281.82M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $66.40M 10-Q · filed 2022-05-10 | $136.97M derived: sum of 2 quarters · filed 2023-03-01 | $204.41M derived: sum of 3 quarters · filed 2023-03-01 | $266.76M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $70.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $138.01M derived: sum of 2 quarters · filed 2023-03-01 | $200.36M derived: sum of 3 quarters · filed 2023-03-01 | $260.89M 10-K · filed 2023-03-01 |
| 2020-09-30 | $67.44M 10-Q · filed 2021-11-09 | $129.79M derived: sum of 2 quarters · filed 2021-11-09 | $190.31M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $62.35M 10-Q · filed 2021-08-05 | $122.88M 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | $182.24M 10-K · filed 2022-02-24 |